- Home
- BTAI vs ULY Comparison
BTAI vs ULY Comparison
Compare BTAI & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- ULY
- Stock Information
- Founded
- BTAI 2017
- ULY 2013
- Country
- BTAI United States
- ULY United States
- Employees
- BTAI N/A
- ULY N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- ULY
- Sector
- BTAI Health Care
- ULY
- Exchange
- BTAI Nasdaq
- ULY Nasdaq
- Market Cap
- BTAI 8.3M
- ULY 7.4M
- IPO Year
- BTAI 2018
- ULY N/A
- Fundamental
- Price
- BTAI $1.81
- ULY $6.01
- Analyst Decision
- BTAI Buy
- ULY Strong Buy
- Analyst Count
- BTAI 5
- ULY 2
- Target Price
- BTAI $34.80
- ULY $13.50
- AVG Volume (30 Days)
- BTAI 325.6K
- ULY 123.7K
- Earning Date
- BTAI 08-05-2025
- ULY 08-11-2025
- Dividend Yield
- BTAI N/A
- ULY N/A
- EPS Growth
- BTAI N/A
- ULY N/A
- EPS
- BTAI N/A
- ULY N/A
- Revenue
- BTAI $1,852,000.00
- ULY $134,085,000.00
- Revenue This Year
- BTAI N/A
- ULY N/A
- Revenue Next Year
- BTAI $362.49
- ULY $23.08
- P/E Ratio
- BTAI N/A
- ULY N/A
- Revenue Growth
- BTAI 5.47
- ULY N/A
- 52 Week Low
- BTAI $1.17
- ULY $2.99
- 52 Week High
- BTAI $19.84
- ULY $20.16
- Technical
- Relative Strength Index (RSI)
- BTAI 48.12
- ULY 44.64
- Support Level
- BTAI $1.70
- ULY $6.06
- Resistance Level
- BTAI $2.00
- ULY $6.92
- Average True Range (ATR)
- BTAI 0.15
- ULY 0.82
- MACD
- BTAI -0.03
- ULY -0.17
- Stochastic Oscillator
- BTAI 20.00
- ULY 0.00
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.